everolimus
Showing 51 - 75 of 435
Thyroid Cancer Trial in Philadelphia (Lenvatinib, Everolimus)
Suspended
- Thyroid Cancer
- Lenvatinib
- Everolimus
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Oct 7, 2021
Breast Cancer, Metastatic Breast Cancer Trial (Elacestrant, Alpelisib, Everolimus)
Not yet recruiting
- Breast Cancer
- Metastatic Breast Cancer
- Elacestrant
- +4 more
- (no location specified)
Sep 28, 2022
Recurrent World Health Organization (WHO) Grade II Glioma Trial in United States (Everolimus, Trametinib)
Recruiting
- Recurrent World Health Organization (WHO) Grade II Glioma
- Everolimus
- Trametinib
-
Birmingham, Alabama
- +11 more
May 6, 2022
Acute Coronary Syndromes Trial in Germany, Switzerland (Everolimus, Placebo)
Completed
- Acute Coronary Syndromes
- Everolimus
- Placebo
-
Bad Nauheim, Germany
- +7 more
Dec 2, 2021
Breast Cancer Trial in Guangzhou (Everolimus, Letrozole, Fluorouracil)
Completed
- Breast Cancer
- Everolimus
- +4 more
-
Guangzhou, Guangdong, ChinaSun-Yat-Sen Memorial Hospital of Sun-Yat-Sen University
Sep 22, 2021
Pediatric Recurrent Progressive Low-grade Gliomas, Pediatric Progressive Low-grade Gliomas Trial in United States (Everolimus)
Active, not recruiting
- Pediatric Recurrent Progressive Low-grade Gliomas
- Pediatric Progressive Low-grade Gliomas
- Everolimus
-
Los Angeles, California
- +17 more
Jun 27, 2022
Epilepsy, Tuberous Sclerosis Complex, Focal Cortical Dysplasia Trial in New York (Everolimus)
Completed
- Epilepsy
- +2 more
- Everolimus
-
New York, New YorkNew York University Langone Medical Center
Aug 31, 2021
Breast Cancer, Ovarian Cancer Trial in Sioux Falls (niraparib, everolimus)
Active, not recruiting
- Breast Cancer
- Ovarian Cancer
- niraparib
- everolimus
-
Sioux Falls, South DakotaAvera Cancer Institute
Aug 24, 2021
Kidney Transplant Infection Trial in São Paulo (Sirolimus, Everolimus, Mycophenolic acid)
Completed
- Kidney Transplant Infection
- Sirolimus
- +2 more
-
São Paulo, Sao Paulo, BrazilHospital do Rim
Aug 23, 2021
Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Villejuif (Everolimus, ONC201, Radiotherapy)
Not yet recruiting
- Diffuse Intrinsic Pontine Glioma
- Diffuse Midline Glioma, H3 K27M-Mutant
- Everolimus
- +2 more
-
Villejuif, Val De Marne, FranceGustave Roussy
Jul 27, 2022
Pancreatic Neuroendocrine Tumors Trial in Beijing, Shanghai, Guangzhou (everolimus)
Active, not recruiting
- Pancreatic Neuroendocrine Tumors
- everolimus
-
Beijing, Beijing, China
- +3 more
Sep 27, 2021
Intracranial Meningioma Trial in United States (Everolimus, Bevacizumab)
Advanced Lung Carcinoid Tumor, Functioning Lung Carcinoid Tumor, Locally Advanced Lung Neuroendocrine Tumor Trial in Boston,
Recruiting
- Advanced Lung Carcinoid Tumor
- +11 more
- Everolimus
- Lutetium Lu 177 Dotatate
-
Boston, Massachusetts
- +1 more
Jul 19, 2022
Breast Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), Placebo (saline), Exemestane)
Completed
- Breast Neoplasms
- Radium-223 dichloride (Xofigo, BAY88-8223)
- +3 more
-
Yuma, Arizona
- +93 more
Nov 4, 2022
Advanced or Metastatic Breast Cancer Trial (PF-07220060, Fulvestrant, Everolimus)
Not yet recruiting
- Advanced or Metastatic Breast Cancer
- PF-07220060
- +3 more
- (no location specified)
Oct 24, 2023
Breast Cancer, Triple Negative Breast Cancer Trial in Houston, Sugar Land (Everolimus)
Completed
- Breast Cancer
- Triple Negative Breast Cancer
- Everolimus
-
Houston, Texas
- +2 more
Jul 16, 2021
Liver Transplant Trial in Boston (biological, procedure, drug)
Recruiting
- Liver Transplant
- arTreg-CSB
- +4 more
-
Boston, MassachusettsMassachusetts General Hospital: Transplantation
Jan 30, 2023
Prostate Cancer Trial in New York (apalutamide, Everolimus)
Completed
- Prostate Cancer
- apalutamide
- Everolimus
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jun 29, 2021
BK Virus Nephropathy After Kidney Transplantation Trial in France (everolimus)
Active, not recruiting
- BK Virus Nephropathy After Kidney Transplantation
- everolimus
-
Amiens, France
- +14 more
Aug 18, 2022
Atypical Endometrial Hyperplasia, FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid
Recruiting
- Atypical Endometrial Hyperplasia
- +2 more
- Everolimus
- +2 more
-
Greeley, Colorado
- +17 more
Jun 13, 2022
Tumors Trial in Worldwide (Everolimus, Exemestane, BI 836845)
Completed
- Neoplasms
- Everolimus
- +2 more
-
Graz, Austria
- +37 more
Feb 2, 2022
Metastatic Colorectal Cancer Trial in Oslo (Alectinib, Cetuximab, Crizotinib)
Recruiting
- Metastatic Colorectal Cancer
- Alectinib
- +16 more
-
Oslo, NorwayOslo University Hospital
Feb 10, 2023